It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...

Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that ...

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

Moderna is downsizing its workforce by 10% globally to bring headcount to under 5,000 in “a difficult moment for the company, ...

The Cambridge-based vaccine maker, which became a household name during the pandemic, is cutting its global workforce to ...

COVID-19 vaccine maker Moderna is cutting approximately 10% of its global workforce as part of a broader cost-reduction ...

The layoffs will affect hundreds of employees globally, though Bancel did not disclose in which areas of the business.

CEO Stéphane Bancel told the Financial Times that he sees ‘no world’ where Moderna’s COVID-19 vaccine works as effectively against the Omicron variant ...

The following is a transcript from the a16z podcast, created by Silicon Valley VC firm Andreessen Horowitz. In this episode, a16z's Jorge Conde and Hanne Winarsky spoke with Stéphane Bancel, CEO of ...

shares rose more than 11 per cent on Tuesday after the vaccine maker’s CEO Stéphane Bancel said in a shareholder letter that the company expects its sales to grow in 2025. “With the expected ...